期刊文献+

机械通气患者呼出气冷凝液收集的临床安全性和可行性 被引量:6

Clinic safety and feasibility of exhaled breath condensate collection in ventilated patients
原文传递
导出
摘要 目的研究机械通气患者呼出气冷凝液(exhaled breath condensate,EBC)收集技术的临床安全性和可行性。方法28例机械通气患者采用改装EcoScreen冷凝器进行93次EBC收集。观察收集前、收集中和收集后三个阶段的呼吸监护和生命体征监护参数的变化。测量EBC收集量并检测其中一氧化氮(NO)和8-异前列烷(8-isoPG)的水平。结果①机械通气患者在EBC收集前与收集后的呼吸监护和生命体征监护参数的差异无统计学意义。②在EBC收集过程中,PSV模式下Vt、f和VM下降;A/C-PC模式下VT、f和VM下降,Pmean升高;A/C-VC模式下VT下降,PIP升高;其变化幅度均小于10%;HR、MAP和Sp02无明显变化。③收集期间VT无进行性下降。④VM为(10.68±4.24)L/min,30min内的EBC收集量为(4.70±1.48)ml。EBC收集量与VM相关(r=0.482,P〈O.01)。⑤机械通气患者EBC中NO和8-isoPG可以检出。结论使用改装Ecoscreen冷凝器对机械通气患者进行EBC采集具有临床安全性和可行性。为减少风险,建议预先评估病情,更换干燥管道,适当提高Vt设置,限制收集时间小于30min。 Objective The aim of this study was to develop a technique for the exhaled breath condensate (EBC) collecting from ventilated patients and assess its clinical safety and feasibility. Methods EBC was collected 93 times from 28 cases with mechanical ventilation by modified EcoScreen condensater. The changes of ventilatory and cilinical parameters were observed before, during, and after three stages of collections,the volume of EBC and the levels of NO and 8-isoPG in EBC were measured at last. Results① There was no statistical significance difference in breathing parameters (PIP, Pmean, Pplat,PEEP, f,VT and VM )and the vital signs (HR, MAP and SpO2 ) of ventilated patients before and after EBC collection in ventilated patients.② During the collection of EBC, the ventilatory parameters slight changed within 10% (VT ,f and VM decreased in PSV. VT ,f and VM decreased and Pmean rised in A/C-PC. VT decreased and PIP rised in A/C-VC),while the clinical parameters (HR,MAP and SpO2 ) did not significant changed. ③ VT did not decrease progressively during the collection. ④The VM was (10.68 ±4.24) L/min, the collection of EBC volume in 30 min was (4.70±1.48) ml. The EBC volume was related to the VM ( r =0, 482, P d0. 01). 0 The NO and 8-isoPG in EBC was detectivable. Conclusions It is clinically safe and feasible to perform EBC collection in ventilated patients using modified EcoScreen condensers. To reduce the risk, it is recommended to assess patient's condition beforehand,to take dry ventilation pipe,to raise the VT set appropriately,and to limit the collecting time in 30 min.
出处 《国际呼吸杂志》 2012年第5期362-366,共5页 International Journal of Respiration
关键词 呼出气冷凝液 EcoScreen冷凝器 机械通气 安全性 Exhaled breath condensate EcoScreen condensater Mechanical ventilation Safety
  • 相关文献

参考文献4

  • 1张文彬,陈建荣,蔡映云.改装EcoScreen冷凝器收集机械通气患者呼出气冷凝液的研究[J].中国呼吸与危重监护杂志,2010,9(4):391-395. 被引量:29
  • 2Muller WG, Morini F, Eaton S,et al. Safety and feasibility of exhaled breath condensate collection in ventilated infants and children. Eur Respir J, 2006,28 : 479-485.
  • 3McCafferty JB, Bradshaw TA, Tate S, et al. Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations. Thorax, 2004,59 : 694-698.
  • 4Schleiss MB, Holz O, Behnke M,et al. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J, 2000,16 : 1115-1118.

二级参考文献10

共引文献28

同被引文献43

  • 1蒋云书,陈建荣,张文彬,蔡映云,陶一江,徐志华,陶国华,陈金亮.急性肺损伤/急性呼吸窘迫综合征患者呼出气冷凝液中血管内皮生长因子A检测的临床意义[J].中国呼吸与危重监护杂志,2011,10(2):135-138. 被引量:8
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 3Decramer M,Rennard S,Troostem T,et al.COPD as a lung disease with systemic consequence-clinical impact,mechanisms,and potential for early intervention[J].COPD,2008,5(4):235-256.
  • 4Effros RM,Su J,Casaburi R,et al.Utility of exhaled breath condensate in chronic obstructive pulmonary disease:a critical review[J].Current Opinion in Pulmonary Medicine,2005,11(2):135-139.
  • 5Montuschi P.Analysis of exhaled breath condensate in respiratory medicine:methodological aspects and potential clinical applications[J].Ther Adv Respir Dis,2007,1(1):5-23.
  • 6Corradj M,Pignatti P,Manini P,et al.Comparison between exhaled and sputum oxidative stress bionlarkers in chronic airway inflammation[J].Eur Respir J,2004,24(6):1011-1017.
  • 7Kostikas K,Papatheodorou G,Ganas K,et al.Ph in expired breath condensate of patients with inflammatory airway diseases[J].Am Respir Crit Care Med,2002,165(10):1364-1370.
  • 8MacNee W. Oxidants/antioxidants and chronic obstructive pulmo- nary disease : pathogenesis to therapy [ J ]. Novartis Found Syrup, 2001,234 : 169 - 185.
  • 9Pauwels R. Global. initiative for chronic obstructive lung diseases (GLOD) : time to act [ J ]. Eur Respir J,2001,18 (6) :901 - 902.
  • 10Effros RM, Su J, Casaburi R, et al. Utility of exhaled breath con- densate in chronic obstructive pulmonary disease: a critical review [J]. Current Opinion in Pulmonary Medicine, 2005, 11 (2) :135- 139.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部